HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effect of dihydroxydibutylether on the lithogenic index of patients with cholesterol gallstones.

Abstract
Daily administration of 900 mg dihydroxydibutylether (DHBE) produced a significant reduction of lithogenic index in patients with cholesterol gallstones. After treatment with placebo, in the same subjects the lithogenic index rises significantly. The activity of DHBE is not casual.
AuthorsG Missale, E Camarri, F Fici, A Agosti, R Di Murro
JournalInternational journal of clinical pharmacology, therapy, and toxicology (Int J Clin Pharmacol Ther Toxicol) Vol. 19 Issue 6 Pg. 273-4 (Jun 1981) ISSN: 0174-4879 [Print] Germany
PMID7309300 (Publication Type: Clinical Trial, Controlled Clinical Trial, Journal Article)
Chemical References
  • Butanols
  • Cholagogues and Choleretics
  • Ethers
  • Lipids
  • Cholesterol
  • 4,4'-oxydi-2-butanol
Topics
  • Adult
  • Bile (analysis, drug effects)
  • Butanols (pharmacology)
  • Cholagogues and Choleretics (pharmacology)
  • Cholelithiasis (drug therapy)
  • Cholesterol (metabolism)
  • Ethers (pharmacology)
  • Female
  • Humans
  • Lipids (analysis)
  • Male
  • Middle Aged

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: